How AI Screening Is Shaping the Future of Drug Discovery with Tom Neyarapally and Mika Newton

Mika Newton and Tom Neyarapally discuss how AI is changing the landscape of drug discovery. They examine the role of machine learning, patient data, and computational tools in accelerating the process, reducing costs, and improving the chances of developing effective treatments. The conversation covers how AI-driven screening, drug repurposing, and real-world data integration are helping to overcome traditional challenges in bringing new therapies to patients faster. They also examine the potential for collaboration between AI technology and clinical expertise to drive future breakthroughs in medicine.